Tissue Products
Our core focus is to harness our in-hous expertise
More...
Biomaterials
With the initial focus on orthopaedic biomaterials and
More...
Products
With a view to maximally harness our in-house technologies and available expertise, EMCM initiated a few research and development projects during the course of its existence. With the initial focus on orthopaedic biomaterials and together with its parent holding aap Implantate AG (
www.aap.de), EMCM currently possesses various types of Bone Cement, Cement Restrictiors as well as an Adhesion Barrier product for Spinal Surgeries in its Biomaterials portfolio.
Bone tissue R&D movie
As the organisation has grown and with the acquisition of key Tissue Processing technologies EMCM now also has Human Bone Allografts, Tissue Constructs and its derivatives in its portfolio. To keep pace with the Medical Aesthetics markets, EMCM also possesses R-Fine, our flagship Hyaluronic Acid product for mesotherapeutic applications.
Currently EMCM does not directly indulge in R&D projects, but our keen focus to enhance our existing products and deepen our product lines has led to our participation in various Tissue Engineering & Biomaterials projects with national and European universities. In this section of the website, we have highlighted our in-house products and a few products in phase of R&D. Please feel free to contact us should you need more information.
Our corporate headquarters at aap Implantate AG, Berlin is primarily focused on the orthopaedic and trauma segments, and thus has a variety of relevant products in its portfolio. To have a detailed overview of these products (Biomaterials and Metal Implants) please visit www.aap.de
